UBS Group’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $160K | Buy |
17,889
+3,917
| +28% | +$39K | ﹤0.01% | 6761 |
|
|
2025
Q4 | $117K | Buy |
13,972
+13,217
| +1,751% | +$133K | ﹤0.01% | 6834 |
|
|
2025
Q3 | $9.06K | Sell |
755
-417
| -36% | -$5.1K | ﹤0.01% | 8625 |
|
|
2025
Q2 | $9.94K | Sell |
1,172
-288
| -20% | -$2.94K | ﹤0.01% | 8868 |
|
|
2025
Q1 | $16.5K | Sell |
1,460
-561
| -28% | -$10.2K | ﹤0.01% | 8354 |
|
|
2024
Q4 | $41.2K | Sell |
2,021
-6,901
| -77% | -$201K | ﹤0.01% | 7417 |
|
|
2024
Q3 | $354K | Buy |
8,922
+8,779
| +6,139% | +$236K | ﹤0.01% | 5467 |
|
|
2024
Q2 | $2.51K | Sell |
143
-168
| -54% | -$2.84K | ﹤0.01% | 8344 |
|
|
2024
Q1 | $5.16K | Buy |
311
+302
| +3,356% | +$4.39K | ﹤0.01% | 7562 |
|
|
2023
Q4 | $170 | Sell |
9
-376
| -98% | -$7.06K | ﹤0.01% | 8850 |
|
|
2023
Q3 | $8.01K | Sell |
385
-6
| -2% | -$182 | ﹤0.01% | 7198 |
|
|
2023
Q2 | $21.3K | Sell |
391
-381
| -49% | -$11.7K | ﹤0.01% | 6841 |
|
|
2023
Q1 | $14K | Sell |
772
-231
| -23% | -$3.98K | ﹤0.01% | 7371 |
|
|
2022
Q4 | $10.2K | Buy |
1,003
+426
| +74% | +$4.56K | ﹤0.01% | 8554 |
|
|
2022
Q3 | $7K | Buy |
577
+568
| +6,311% | +$8.6K | ﹤0.01% | 8898 |
|
|
2022
Q2 | $0 | Sell |
9
-20
| -69% | -$529 | ﹤0.01% | 10836 |
|
|
2022
Q1 | $1K | Sell |
29
-332
| -92% | -$14.1K | ﹤0.01% | 9911 |
|
|
2021
Q4 | $16K | Buy |
361
+43
| +14% | +$2.3K | ﹤0.01% | 8176 |
|
|
2021
Q3 | $21K | Sell |
318
-424
| -57% | -$32.2K | ﹤0.01% | 7113 |
|
|
2021
Q2 | $75K | Buy |
742
+451
| +155% | +$46.5K | ﹤0.01% | 6097 |
|
|
2021
Q1 | $38K | Buy |
291
+198
| +213% | +$29.3K | ﹤0.01% | 6805 |
|
|
2020
Q4 | $10K | Buy |
93
+84
| +933% | +$9.41K | ﹤0.01% | 7497 |
|
|
2020
Q3 | $1K | Sell |
9
-196
| -96% | -$33.9K | ﹤0.01% | 7825 |
|
|
2020
Q2 | $44K | Sell |
205
-216
| -51% | -$51K | ﹤0.01% | 5964 |
|
|
2020
Q1 | $95K | Sell |
421
-403
| -49% | -$115K | ﹤0.01% | 5335 |
|
|
2019
Q4 | $221K | Buy |
824
+332
| +67% | +$83.5K | ﹤0.01% | 5538 |
|
|
2019
Q3 | $150K | Buy |
492
+364
| +284% | +$112K | ﹤0.01% | 5470 |
|
|
2019
Q2 | $43K | Buy |
128
+84
| +191% | +$42.7K | ﹤0.01% | 6052 |
|
|
2019
Q1 | $27K | Sell |
44
-226
| -84% | -$103K | ﹤0.01% | 6038 |
|
|
2018
Q4 | $67K | Buy |
270
+57
| +27% | +$22.7K | ﹤0.01% | 5862 |
|
|
2018
Q3 | $99K | Buy |
213
+46
| +28% | +$22.3K | ﹤0.01% | 5613 |
|
|
2018
Q2 | $90K | Buy |
167
+116
| +227% | +$69.6K | ﹤0.01% | 5517 |
|
|
2018
Q1 | $29K | Sell |
51
-20
| -28% | -$12.6K | ﹤0.01% | 6119 |
|
|
2017
Q4 | $45K | Sell |
71
-19
| -21% | -$13.4K | ﹤0.01% | 5921 |
|
|
2017
Q3 | $85K | Buy |
90
+7
| +8% | +$5.36K | ﹤0.01% | 5414 |
|
|
2017
Q2 | $73K | Sell |
83
-520
| -86% | -$426K | ﹤0.01% | 5384 |
|
|
2017
Q1 | $415K | Sell |
603
-67
| -10% | -$44.2K | ﹤0.01% | 4176 |
|
|
2016
Q4 | $483K | Buy |
670
+71
| +12% | +$49.1K | ﹤0.01% | 4146 |
|
|
2016
Q3 | $441K | Sell |
599
-69
| -10% | -$55.9K | ﹤0.01% | 3995 |
|
|
2016
Q2 | $556K | Buy |
668
+42
| +7% | +$39.1K | ﹤0.01% | 3806 |
|
|
2016
Q1 | $517K | Buy |
626
+197
| +46% | +$155K | ﹤0.01% | 3752 |
|
|
2015
Q4 | $483K | Sell |
429
-63
| -13% | -$73.3K | ﹤0.01% | 3977 |
|
|
2015
Q3 | $417K | Buy |
492
+319
| +184% | +$462K | ﹤0.01% | 4058 |
|
|
2015
Q2 | $307K | Sell |
173
-128
| -43% | -$163K | ﹤0.01% | 4501 |
|
|
2015
Q1 | $362K | Sell |
301
-113
| -27% | -$132K | ﹤0.01% | 4399 |
|
|
2014
Q4 | $468K | Buy |
+414
| New | +$425K | ﹤0.01% | 4262 |
|
Other funds holding RMTI
VCM
VFT
WANY
UBS Group's RMTI Position: Q1 2026 in Review
UBS Group increased its Rockwell Medical (RMTI) stake by 28% in Q1 2026, buying an estimated $39K and bringing the position to 17,889 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #6761.
UBS Group first reported a position in RMTI in Q4 2014 and has held it in 46 quarters since. The position peaked at $556K in Q2 2016. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- UBS Group held 17,889 shares of Rockwell Medical worth $160K as of Q1 2026.
- UBS Group bought 3,917 Rockwell Medical shares in Q1 2026, an estimated $39K.
- Rockwell Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6761 holding.
- UBS Group first reported a position in Rockwell Medical in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Rockwell Medical position peaked at $556K in Q2 2016.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.